CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BMO Capital Adjusts Price Target on Biogen to $208 From $196, Maintains Market Perform Rating

Neutral
AI Analysis

Summary

BMO Capital adjusted its price target for Biogen from $196 to $208 while maintaining a Market Perform rating.

Importance:2/10
Sentiment:
0.00
price_target_adjustmentanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on July 30, 2026 3:12 PM

Read Original